- Home
- KALA vs MGRX Comparison
KALA vs MGRX Comparison
Compare KALA & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- MGRX
- Stock Information
- Founded
- KALA 2009
- MGRX 2021
- Country
- KALA United States
- MGRX United States
- Employees
- KALA N/A
- MGRX N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- MGRX Computer Software: Prepackaged Software
- Sector
- KALA Health Care
- MGRX Technology
- Exchange
- KALA Nasdaq
- MGRX Nasdaq
- Market Cap
- KALA 26.2M
- MGRX 25.2M
- IPO Year
- KALA 2017
- MGRX 2023
- Fundamental
- Price
- KALA $0.81
- MGRX $2.19
- Analyst Decision
- KALA Buy
- MGRX
- Analyst Count
- KALA 3
- MGRX 0
- Target Price
- KALA $31.50
- MGRX N/A
- AVG Volume (30 Days)
- KALA 1.3M
- MGRX 287.0K
- Earning Date
- KALA 11-07-2025
- MGRX 11-13-2025
- Dividend Yield
- KALA N/A
- MGRX N/A
- EPS Growth
- KALA N/A
- MGRX N/A
- EPS
- KALA N/A
- MGRX N/A
- Revenue
- KALA N/A
- MGRX $516,030.00
- Revenue This Year
- KALA N/A
- MGRX N/A
- Revenue Next Year
- KALA N/A
- MGRX N/A
- P/E Ratio
- KALA N/A
- MGRX N/A
- Revenue Growth
- KALA N/A
- MGRX N/A
- 52 Week Low
- KALA $0.77
- MGRX $1.32
- 52 Week High
- KALA $20.60
- MGRX $6.15
- Technical
- Relative Strength Index (RSI)
- KALA 26.24
- MGRX 46.37
- Support Level
- KALA $0.77
- MGRX $2.14
- Resistance Level
- KALA $1.52
- MGRX $2.50
- Average True Range (ATR)
- KALA 0.10
- MGRX 0.27
- MACD
- KALA 0.31
- MGRX -0.04
- Stochastic Oscillator
- KALA 4.56
- MGRX 16.42
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.